Sequence Similarity Clusters for the Entities in PDB 1FNS

Entity #1 | Chains: L
IMMUNOGLOBULIN NMC-4 IGG1 protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 31317
95 % 9 54 585 Flexibility: Low
Max RMSD: 4.8, Avg RMSD: 1.9
PDBFlex
90 % 10 68 417
70 % 447 2576 1
50 % 918 5225 1
40 % 1109 5883 1
30 % 1353 7321 1
Entity #2 | Chains: H
IMMUNOGLOBULIN NMC-4 IGG1 protein, length: 225 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 56791
95 % 1 2 30827 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 1 11 6373
70 % 448 2532 2
50 % 919 5225 1
40 % 1110 5883 1
30 % 1354 7321 1
Entity #3 | Chains: A
VON WILLEBRAND FACTOR protein, length: 196 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 4 21157
95 % 2 14 3706 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.0
PDBFlex
90 % 2 14 3776
70 % 2 15 3495
50 % 2 15 3412
40 % 2 15 3288
30 % 2 15 3041

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 5YD4 1 A, C, E, G scFv 4B08 10090
32 5YD3 1 A, C, E, G scFv 4B08 10090
33 2XT1 2 B CAMELID VHH 9 30538
34 5UD9 1 H Fab heavy chain 9606
35 5UD9 2 L Light chain 9606
36 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
37 4P48 1 A Antibody scFv 180 9031
38 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
39 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
40 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
41 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
42 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
43 5J1S 3 C VHH domain BS-2 30538
44 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
45 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
46 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
47 5J1T 3 C VHH domain BS-2 30538
48 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
49 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
50 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
51 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
52 4XCF 1 L 4E10 Fab light chain 9606
53 4XCF 2 H 4E10 Fab heavy chain 9606
54 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
55 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
56 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
57 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
58 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
59 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
60 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
61 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
62 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
63 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
64 5X08 1 H Fab 4E10 Heavy chain 9606
65 5X08 2 L Fab 4E10 Light chain 9606
66 2X1O 1 A, B GELSOLIN NANOBODY 9844
67 4QGY 1 A, B nanobody n25, VH domain 9844
68 5C2B 1 H scFv 3B4 heavy chain 9606
69 4XAW 1 L 4E10 Fab light chain 9606
70 4XAW 2 H 4E10 Fab heavy chain 9606
71 5VNV 1 A Nb.b201 32630
72 4P49 1 A Antibody scFv B8 9031
73 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
74 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
75 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
76 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
77 5DXW 1 A PD-L1 nanobody 10090
78 5UCB 1 H Fab Heavy Chain 9606
79 5UCB 2 L Fab Light Chain 9606
80 2VXV 1 H HUMAN IGG ABT-325 9606
81 2VXV 2 L HUMAN IGG ABT-325 9606
82 4N9O 2 B Nanobody Nb484 Nb484 9844
83 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
84 4GXV 1 H, I Antibody 1F1, heavy chain 9606
85 4GXV 2 L, M Antibody 1F1, light chain 9606
86 2VXT 1 H MURINE IGG 125-2H 10090
87 2VXT 3 L MURINE IGG 125-2H 10090
88 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
89 1T2J 1 A M12-Variable Heavy domain 9606
90 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
91 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
92 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
93 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
94 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
95 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
96 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
97 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
98 5W24 1 L 5C4 Fab Light Chain 10090
99 5W24 2 H 5C4 Fab Heavy Chain 10090
100 4HPY 1 H CH59 Fab heavy chain 9606
101 4HPY 2 L CH59 Fab light chain 9606
102 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
103 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
104 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
105 5VM6 1 A single domain camelid nanobody VHH T10 9844
106 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
107 4JG1 1 L Fab light chain 9606
108 4JG1 2 H Fab heavy chain 9606
109 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
110 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
111 4KML 2 B Nanobody 9844
112 5VF2 1 A scFv 2D10 10090
113 5I8C 1 A VRC34.01 Fab heavy chain 9606
114 5I8C 2 B VRC34.01 Fab light chain 9606
115 4O5L 1 L Fab F045-092 light chain 9606
116 4O5L 2 H Fab F045-092 heavy chain 9606
117 5MYX 1 A, C Fab c#24 light chain 10090
118 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
119 4Z9K 2 B VHH2(F5) antibody 30538
120 3IFL 1 L 12A11 FAB antibody light chain 10090
121 3IFL 2 H 12A11 FAB antibody heavy chain 10090
122 5WK2 1 L M116 LIGHT CHAIN 9606
123 5WK2 2 H M116 HEAVY CHAIN FD 9606
124 3PP4 1 H GA101 Fab heavy chain 10090
125 3PP4 2 L GA101 Fab light chain 10090
126 3KDM 1 A, L Immunoglobulin light chain 9606
127 3KDM 2 B, H Immunoglobulin heavy chain 9606
128 5NIV 1 A Light chain of 5D3 Fab 10090
129 5NIV 2 B Heavy chain of 5D3 Fab 10090
130 5N4J 1 L LIGHT CHAIN 9606
131 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
132 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
133 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
134 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
135 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
136 5X4G 1 A 6H8 Fab heavy chain 10090
137 5X4G 2 B 6H8 Fab light chain 10090
138 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
139 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
140 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
141 4PTU 1 A Antibody pn132p2C05, light chain 9606
142 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
143 4TPR 1 L If kappa light chain 10090
144 4TPR 2 H Fab heavy chain 10090
145 5LMW 1 A Nanobody 9844
146 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
147 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
148 3IFN 1 H 12A11 FAB antibody heavy chain 10090
149 3IFN 2 L 12A11 FAB antibody light chain 10090
150 5U3P 1 H DH511.4 Fab Heavy Chain 9606
151 5U3P 2 L DH511.4 Fab Light Chain 9606
152 6BLA 1 H AMM01 Fab Heavy chain 9606
153 6BLA 2 L AMM01 Fab Light chain 9606
154 5NM0 1 A, B, C, D Nb36 9844
155 4TOY 1 H 35O22 Fab Heavy chain 9606
156 4TOY 2 L 35O22 Fab Light chain 9606
157 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
158 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
159 3NPS 2 B S4 FAB HEAVY CHAIN 9606
160 3NPS 3 C S4 FAB LIGHT CHAIN 9606
161 5I4F 1 A scFv 2D10 10090
162 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
163 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
164 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
165 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
166 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
167 5WN9 1 H scFv 2D10 9606
168 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
169 4XC3 1 L 4E10 Fab light chain 9606
170 4XC3 2 H 4E10 Fab heavy chain 9606
171 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
172 4PPT 1 A Engineered single domain VHH antibody 9844
173 3R0M 1 A, B Llama VHH A12 9844
174 4M5Y 1 H, I Fab 5J8 heavy chain 9606
175 4M5Y 2 L, M Fab 5J8 light chain 9606
176 4TQE 1 L If kappa light chain 10090
177 4TQE 2 H Fab heavy chain 10090
178 3ZKQ 2 D XA4813 9844
179 4I13 2 B Protein ca1697 (nanobody) 9844
180 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
181 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
182 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
183 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
184 5C2U 1 B Nanobody Nanobody 9838
185 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
186 5VSI 2 L CH1/Ckappa Fab light chain 9606
187 1XFP 1 A heavy chain antibody VHH domain 9838
188 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
189 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
190 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
191 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
192 5JXA 1 H VRC03 Heavy chain 9606
193 5JXA 2 L VRC03 Light chain 9606
194 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
195 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
196 4POY 1 A VHH-metal 9844
197 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
198 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
199 5NLW 1 A nanobody Nb36 9844
200 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
201 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
202 3NTC 1 L Fab light chain 10090
203 3NTC 2 H Fab heavy chain 10090
204 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
205 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
206 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
207 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
208 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
209 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
210 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
211 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
212 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
213 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
214 6BE3 1 H Fab (F598) Heavy Chain 9606
215 6BE3 2 L Fab (F598) Light Chain 9606
216 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
217 3G9A 2 B Minimizer 9838
218 4NWU 1 H APE1551 Ab Fab heavy chain 9606
219 4NWU 2 L APE1551 Ab Fab light chain 9606
220 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
221 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
222 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
223 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
224 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
225 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
226 5EWI 1 H VRC38.01 Heavy Chain 9606
227 5EWI 2 L VRC38.01 Light Chain 9606
228 5E2W 1 L AT8 LIGHT CHAIN 10090
229 5E2W 2 H AT8 HEAVY CHAIN 10090
230 5MYK 1 A Fab c#17 light chain 10090
231 5MYK 2 B Fab c#17 heavy chain 10090
232 4NZR 1 H PGT135 heavy chain Fab 9606
233 4NZR 2 L PGT135 light chain Fab 9606
234 5MYO 1 A, C Fab c#6 light chain 10090
235 5MYO 2 B, D Fab c#6 heavy chain 10090
236 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
237 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
238 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
239 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
240 5UEL 1 H 354NC102 Fab Heavy Chain 9606
241 5UEL 2 L 354NC102 Fab Light Chain 9606
242 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
243 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
244 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
245 2P43 2 B ANTIBODY CAB-RN05 9838
246 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
247 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
248 5E2V 1 L AT8 LIGHT CHAIN 10090
249 5E2V 2 H AT8 HEAVY CHAIN 10090
250 4KRN 1 A Nanobody/VHH domain EgA1 9844
251 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
252 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
253 4GFT 2 B Nanobody 9844
254 4TVS 2 a, b VHH Domain BS-1 30538
255 4W6Y 2 B Nanobody NbFedF9 9844
256 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
257 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
258 6EZW 1 B VHH antibody BCD090-M2 9844
259 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
260 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
261 5JUE 1 L light chain of UIC2 Fab 10090
262 5JUE 2 H heavy chain of UIC2 Fab 10090
263 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
264 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
265 1UAC 2 H Ig VH,anti-lysozyme 10090
266 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
267 5JR1 1 H 10E8 heavy chain 9606
268 5JR1 2 L 10E8 mature light chain 9606
269 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
270 6CA7 1 L PCT64_13C light chain 9606
271 6CA7 2 H PCT64_13C heavy chain 9606
272 5VF6 1 A single chain variable fragment 9031
273 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
274 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
275 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
276 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
277 5OB5 2 H fAb Heavy chain 9606
278 5OB5 3 L fAb Light chain 9606
279 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
280 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
281 5I66 1 A 8B6 antibody, heavy chain 10090
282 5I66 2 B 8B6 antibody, light chain 10090
283 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
284 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
285 6BZY 1 H 22D11 Heavy Chain 10090
286 6BZY 2 L 22D11 Light Chain 10090
287 3QQ9 1 C, L 101F LIGHT CHAIN 10090
288 3QQ9 2 D, H 101F HEAVY CHAIN 10090
289 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
290 5TKK 3 L mouse antibody vFP5.01 light chain 10090
291 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
292 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
293 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
294 5W6C 1 H UCA Fab heavy chain 9606
295 5W6C 2 L UCA Fab light chain 9606
296 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
297 5I1K 1 L FAB LIGHT CHAIN 9606
298 5I1K 2 H FAB HEAVY CHAIN 9606
299 3OZ9 1 L Fab NC-1 kappa light chain 10090
300 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
301 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
302 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
303 5V7U 1 L CBTAU-22.1 Fab light chain 9606
304 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
305 5UEA 1 A, H Fab Heavy Chain 9606
306 5UEA 3 B, L Fab Light Chain 9606
307 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
308 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
309 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
310 3G5Y 1 A 175 light chain 10090
311 3G5Y 2 B 175 heavy chain 10090
312 5O02 2 C Nanobody (VHH) Nano-4 30538
313 5NMV 1 L Fab light chain 10088
314 5NMV 2 H Fab heavy chain 10088
315 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
316 4N8C 2 L, M Light chain of monoclonal antibody 10090
317 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
318 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
319 4HGW 1 A Antibody Fab fragment, light chain 10090
320 4HGW 2 B Antibody Fab fragment, heavy chain 10090
321 1NLB 1 L antibody 19D9D6 light chain 10090
322 1NLB 2 H antibody 19D9D6 heavy chain 10090
323 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
324 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
325 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
326 3VFG 1 L 3F8 Light Chain 10090
327 3VFG 2 H 3F8 Heavy Chain 10090
328 4X7F 2 C, D Nano-25 Nanobody 30538
329 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
330 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
331 3QRG 1 L Fab light chain 9606
332 3QRG 2 H Fab heavy chain Fd fragment 9606
333 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
334 5M6A 1 A, B, C, D Bence-Jones light chain 9606
335 4LLY 2 B, D light chain Clambda 9606
336 4LGR 2 B Camelid nanobody (VHH3) 30538
337 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
338 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
339 5EZI 1 H Fab c12 heavy chain 9606
340 5EZI 2 L Fab c12 Light chain 9606
341 4K23 1 H anti-uPAR antibody, heavy chain 10090
342 4K23 2 L anti-uPAR antibody, light chain 10090
343 5J57 2 B VHH single chain antibody V5E1 30538
344 3NCJ 1 L Fab15 Mut8 light chain 9606
345 3NCJ 2 H Fab15 Mut8 heavy chain 9606
346 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
347 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
348 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
349 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
350 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
351 5W05 1 L M59 FAB LIGHT CHAIN 10090
352 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
353 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
354 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
355 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
356 5OMM 2 C Nanobody (VHH) Nano-14 30538
357 5E03 1 A mouse CTLA-4 nanobody 10090
358 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
359 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
360 4M61 1 A, C Fab A52 light chain 10090
361 4M61 2 B, D Fab A52 heavy chain 10090
362 5LZ0 1 A, B PorM nanobody 9844
363 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
364 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
365 1UM5 1 L Antibody 21H3 L chain 10090
366 1UM5 2 H Antibody 21H3 H chain 10090
367 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
368 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
369 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
370 4NWT 1 L APE1531 Ab Fab light chain 9606
371 4NWT 2 H APE1531 Ab Fab heavy chain 9606
372 3WHX 1 A mAb Fab H fragment 10090
373 3WHX 2 B mAb Fab L fragment 10090
374 3NA9 1 L Fab15 light chain 9606
375 3NA9 2 H Fab15 heavy chain 9606
376 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
377 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
378 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
379 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
380 4LRI 1 A, B MSL-109 Light Chain 9606
381 4LRI 2 C, P MSL-109 Heavy Chain 9606
382 2XXC 1 B CAMELID VHH 9 30538
383 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
384 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
385 4JN2 1 A, L anti dabigatran Fab 10090
386 4JN2 2 B, H anti dabigatran Fab 10090
387 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
388 4XBE 2 H 4E10 Fab heavy chain 9606
389 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
390 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
391 6BE2 1 H Fab (F598) Heavy Chain 9606
392 6BE2 2 L Fab (F598) Light Chain 9606
393 3QYC 1 A, B VH domain of IgG molecule 9606
394 4JFZ 1 L Fab light chain 9606
395 4JFZ 2 H Fab heavy chain 9606
396 5VAK 2 B Nb914 Nanobody 9844
397 3WIF 1 A mAb Fab H fragment 10090
398 3WIF 2 B mAb Fab L fragment 10090
399 5U6A 1 A Light Chain 9606
400 5U6A 2 B Heavy Chain 9606
401 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
402 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
403 3MBX 1 L X836 LIGHT CHAIN 10090
404 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
405 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
406 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
407 2XXM 2 B CAMELID VHH 9 30538
408 6APC 1 H Epididymis luminal protein 214 9606
409 6APC 2 L IGL@ protein 9606
410 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
411 4HHA 1 A Fab KE5 Fab fragment KE5 9606
412 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
413 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
414 4RGO 2 H 14G8 heavy chain Fab 10090
415 4RGO 3 L 14G8 light chain Fab 10090
416 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
417 5GRY 1 A, G diabody 9606
418 5UEK 2 H Fab 12E Heavy Chain 9606
419 5UEK 3 L Fab 12E Light Chain 9606
420 3NAA 1 L Fab15 Mut5 light chain 9606
421 3NAA 2 H Fab15 Mut5 heavy chain 9606
422 1Q0X 1 L Fab 9B1, light chain 10090
423 1Q0X 2 H Fab 9B1, heavy chain 10090
424 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
425 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
426 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
427 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
428 5JDS 1 B Nanobody 9835
429 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
430 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
431 5IK3 2 B, D 1E03 Fab fragment light chain 9606
432 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
433 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
434 5XLI 1 a, b FabL 10090
435 5XLI 2 c, d FabH 10090
436 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
437 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
438 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
439 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
440 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
441 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
442 4WUK 1 H CH65 heavy chain 9606
443 4WUK 2 L CH65 light chain 9606
444 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
445 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
446 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
447 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
448 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
449 5JOP 1 D, L Fab 14.22 light chain 10090
450 5JOP 2 E, H Fab14.22 heavy chain 10090
451 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
452 4HPO 1 H CH58 Fab heavy chain 9606
453 4HPO 2 L CH58 Fab light chain 9606
454 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
455 5UKN 2 L DH522UCA Fab fragment light chain 9544
456 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
457 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
458 5L21 2 B VHH-C2 30538
459 5IT2 1 H heavy chain 9606
460 5IT2 2 L light chain 9606
461 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
462 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
463 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
464 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
465 5FWO 1 A NANOBODY 9844
466 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
467 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
468 5MO3 3 L Fab of monoclonal antibody, light chain 10090
469 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
470 5GZ0 1 A, C FM329 light chain 1383439
471 5GZ0 2 B, D FM329 heavy chain 1383439
472 3B9V 1 A, B, C, D heavy chain variable domain 9606
473 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
474 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
475 6BQB 1 L MGG4 Fab light chain 9606
476 6BQB 2 H MGG4 Fab heavy chain 9606
477 4PUB 1 H DX-2930 HEAVY CHAIN 9606
478 4PUB 2 L DX-2930 LIGHT CHAIN 9606
479 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
480 6B14 2 L Light chain of Fab BL3-6S97N 10090
481 5N88 1 A, H VH59 antibody 9606
482 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
483 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
484 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
485 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
486 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
487 5GS3 1 A, H diabody protein 9606
488 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
489 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
490 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
491 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
492 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
493 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
494 5VKD 2 H Fab Heavy Chain 9606
495 5VKD 3 L Fab light chain 9606
496 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
497 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
498 5XHG 1 A, C polypeptide(L) 562
499 5XHG 2 B, D polypeptide(H) 562
500 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
501 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
502 3UYR 1 H antibody Fab heavy chain 10090
503 3UYR 2 L antibody Fab light chain 10090
504 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
505 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
506 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
507 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
508 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
509 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
510 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
511 3OAZ 2 K, L Fab 2G12, light chain 9606
512 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
513 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
514 1ZAN 1 L Fab AD11 Light Chain 10116
515 1ZAN 2 H Fab AD11 Heavy Chain 10116
516 4N0Y 1 H IGH526 Heavy Chain 9606
517 4N0Y 2 L IGH526 Light Chain 9606
518 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
519 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
520 5MTH 1 A, H antibody Fab heavy chain 10090
521 5MTH 2 B, L antibody Fab light chain 10090
522 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
523 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
524 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
525 1RZF 1 L Fab E51 light chain 9606
526 1RZF 2 H Fab E51 heavy chain 9606
527 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
528 4KTE 2 L GE148 Light Chain Fab 9544
529 5I8O 1 H HMM5 antibody heavy chain 9606
530 5I8O 2 L HMM5 antibody light chain 9606
531 4OUO 1 A anti Bla g 1 scFv 9031
532 4JG0 1 L Fab light chain 9606
533 4JG0 2 H Fab heavy chain 9606
534 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
535 4YGV 2 B, L aDabi-Fab2a light chain 9606
536 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
537 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
538 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
539 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
540 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
541 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
542 3EO0 1 A, C GC-1008 Fab Light Chain 10090
543 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
544 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
545 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
546 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
547 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
548 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
549 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
550 4POU 2 B VHH Antibody 9844
551 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
552 4FQI 3 H antibody CR9114 heavy chain Fab 9606
553 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
554 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
555 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
556 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
557 4JHA 2 L D25 light chain 9606
558 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
559 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
560 4PTT 1 A Antibody pn132p2C05, light chain 9606
561 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
562 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
563 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
564 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
565 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
566 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
567 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
568 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
569 2P42 2 B, D ANTIBODY CAB-RN05 9838
570 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
571 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
572 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
573 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
574 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
575 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
576 4DGV 1 H HCV1 Heavy Chain Fab 9606
577 4DGV 2 L HCV1 Light Chain 9606
578 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
579 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
580 5TH2 1 A, C cetuximab Fab, light chain 10090
581 5TH2 2 B, D cetuximab Fab, heavy chain 10090
582 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
583 5I8K 1 L HHH1 Fab Light chain 9606
584 5I8K 2 H HHH1 Fab Heavy chain 9606
585 4QLR 1 A, B Llama nanobody n02 VH domain 9844
586 5J56 2 B VHH single chain antibody V1C7 30538
587 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
588 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
589 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
590 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
591 1YNL 1 L Ig gamma light chain 10090
592 1YNL 2 H Ig gamma heavy chain 10090
593 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
594 5EPM 2 B, F Antibody Fab fragment light chain 10090
595 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
596 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
597 3UMT 1 A scFv heavy chain and light chain 10090
598 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
599 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
600 4NUJ 1 A PGT152 light chain 9606
601 4NUJ 2 B PGT152 heavy chain 9606
602 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
603 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
604 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
605 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
606 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
607 3U2S 2 B, L PG9 light chain 9606
608 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
609 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
610 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
611 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
612 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
613 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
614 4NUG 1 L PGT151 light chain 9606
615 4NUG 2 H PGT151 heavy chain 9606
616 3IU4 1 H chP3 Fab heavy chain 10090
617 3IU4 2 L chP3 Fab light chain 10090
618 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
619 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
620 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
621 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
622 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
623 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
624 1P7K 1 A, L antibody light chain FAB 10090
625 1P7K 2 B, H antibody heavy chain FAB 10090
626 4NBX 2 B A20.1 VHH 9844
627 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
628 3RVV 2 C 4C1 - light chain 10090
629 3RVV 3 D 4C1 - heavy chain 10090
630 4HEP 2 G vHH17 domain 9844
631 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
632 3P0Y 2 H Fab DL11 heavy chain 9606
633 3P0Y 3 L Fab DL11 light chain 9606
634 4NPY 1 A, L germline PGT121 light chain Fab 9606
635 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
636 6ANA 2 H LL2 Fab Heavy Chain 10090
637 6ANA 3 L LL2 Fab Light Chain 10090
638 5IBU 1 B, L 6652 Light Chain 9606
639 5IBU 2 G, H 6652 Heavy Chain 9606
640 5VPL 2 C 4C1 - LIGHT CHAIN 10090
641 5VPL 3 D 4C1 - HEAVY CHAIN 10090
642 6AOD 1 A FXIa Antibody FAB Light Chain 9606
643 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
644 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
645 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
646 2YPV 2 H FAB 12C1 10090
647 2YPV 3 L FAB 12C1 10090
648 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
649 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
650 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
651 4JY5 1 L PGT122 light chain Fab 9606
652 4JY5 2 H PGT122 heavy chain Fab 9606
653 6ELE 1 A, H fAB heavy chain 9606
654 6ELE 2 B, L fAB light chain 9606
655 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
656 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
657 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
658 6B5R 1 H CIS42 Fab Heavy chain 9606
659 6B5R 2 L CIS42 Fab Light chain 9606
660 5IML 2 B Nanobody 9835
661 3NAC 1 L Fab15 Mut7 light chain 9606
662 3NAC 2 H Fab15 Mut7 heavy chain 9606
663 3A6C 2 H IG VH, anti-lysozyme 10090
664 2DQD 2 H Ig VH,anti-lysozyme 10090
665 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
666 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
667 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
668 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
669 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
670 1Q72 1 L Fab M82G2, Light chain 10090
671 1Q72 2 H Fab M82G2, Heavy chain 10090
672 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
673 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
674 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
675 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
676 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
677 4YHO 1 H aDabi-Fab3 heavy chain 9606
678 4YHO 2 L aDabi-Fab3 light chain 9606
679 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
680 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
681 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
682 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
683 4DGY 1 H HCV1 Heavy Chain Fab 9606
684 4DGY 2 L HCV1 Light Chain 9606
685 3A67 2 H IG VH, anti-lysozyme 10090
686 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
687 5EN2 1 A GD01 heavy chain 10090
688 5EN2 2 B GD01 light chain 10090
689 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
690 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
691 1J1X 2 H Ig VH,anti-lysozyme 10090
692 5M2J 2 D Anti-(ED-B) scFV 9606
693 3MXW 2 L 5E1 light chain 9606
694 3MXW 3 H 5E1 heavy chain 9606
695 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
696 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
697 2DQC 2 H Ig VH,anti-lysozyme 10090
698 1J1O 2 H Ig VH,anti-lysozyme 10090
699 3EO9 1 L Efalizumab Fab fragment, light chain 9606
700 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
701 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
702 4M62 2 H, I GEP2 FV heavy chain 9606
703 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
704 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
705 5IVO 1 A BC2-nanobody 30538
706 1J1P 2 H Ig VH,anti-lysozyme 10090
707 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
708 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
709 4NBZ 2 B, D A26.8 VHH 9844
710 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
711 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
712 5WUV 1 L light chain 9606
713 5WUV 2 H heavy chain 9606
714 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
715 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
716 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
717 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
718 5AYU 2 H Ig VH,anti-lysozyme 10090
719 4JM4 1 H PGT 135 Heavy Chain Fab 9606
720 4JM4 2 L PGT 135 Light Chain Fab 9606
721 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
722 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
723 3A6B 2 H IG VH, anti-lysozyme 10090
724 2DQJ 2 H Ig VH,anti-lysozyme 10090
725 5F21 2 B nanobody MU375 9844
726 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
727 6B0G 1 C 1245 Antibody, Light Chain 9606
728 6B0G 2 D 1245 Antibody, Heavy Chain 9606
729 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
730 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
731 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
732 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
733 6D0X 1 A 2140 Antibody, heavy chain 9606
734 6D0X 2 B 1210 Antibody, light chain 9606
735 2P44 2 B ANTIBODY CAB-RN05 9838
736 6BE4 1 H Fab (F598) Heavy Chain 9606
737 6BE4 2 L Fab(F598) Light Chain 9606
738 5TPP 1 L DH270.5 Fab heavy chain 9606
739 5TPP 2 H DH270.5 Fab light chain 9606
740 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
741 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
742 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
743 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
744 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
745 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
746 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
747 5TP3 1 A, B F-VHH-4 9844
748 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
749 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
750 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
751 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
752 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
753 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
754 5TL5 1 L M2177 LIGHT CHAIN 10090
755 5TL5 2 H M2177 HEAVY CHAIN 10090
756 2FX7 1 L Fab 4E10 Light Chain 9606
757 2FX7 2 H Fab 4E10 Heavy Chain 9606
758 5Y9K 1 L belimumab light chain 9606
759 5Y9K 2 H belimumab heavy chain 9606
760 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
761 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
762 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
763 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
764 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
765 4LHJ 2 B Camelid antibody 30538
766 3WFH 1 A mAb Fab H fragment 10090
767 3WFH 2 B mAb Fab L fragment 10090
768 4BEL 2 D, E XA4813 9844
769 5M7Q 1 A, B Nanobody NbD2 9838
770 5H8D 1 A VHH nanobody 9844
771 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
772 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
773 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
774 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
775 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
776 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
777 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
778 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
779 3DUR 2 B, D Ig-like protein 10090
780 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
781 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
782 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
783 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
784 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
785 5HI4 3 D, L CAT-2000 FAB light chain 9606
786 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
787 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
788 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
789 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
790 3RVW 2 C 4C1 - light chain 10090
791 3RVW 3 D 4C1 - heavy chain 10090
792 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
793 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
794 5XKU 2 B HNIgGA6 light chain 9606
795 5XKU 3 C HNIgGA6 heavy chain 9606
796 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
797 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
798 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
799 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
800 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
801 5HI5 3 D, L CAT-2000 light chain 9606
802 5JO5 1 A, C, E, H 10E8 gHV 9606
803 5JO5 2 B, D, F, L 10E8 gLV 9606
804 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
805 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
806 2XV6 2 B, D CAMELID VHH 9 30538
807 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
808 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
809 5CCK 2 L Antibody 3BC315 Fab light chain 9606
810 5VM0 1 A, B Camelid Nanobody VHH T9 9844
811 5I76 1 A, C FM318_light_chain 1383439
812 5I76 2 B, D FM318_heavy_cahin 1383439
813 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
814 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
815 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
816 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
817 5I18 1 L FAB LIGHT CHAIN 9606
818 5I18 2 H FAB HEAVY CHAIN 9606
819 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
820 4JN1 2 L anti-dabigatran Fab1, light chain 10090
821 4ZG1 1 A, B, C, D, E, F NB17 9844
822 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
823 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
824 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
825 4G5Z 2 L canakinumab antibody fragment light chain 9606
826 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
827 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
828 2OK0 2 L Fab ED10 light chain 10090
829 2OK0 3 H Fab ED10 heavy chain 10090
830 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
831 3SOB 1 L antibody light chain 9606
832 3SOB 3 H antibody heavy chain 9606
833 6B5M 1 H CIS43 Fab Heavy chain 9606
834 6B5M 2 L CIS43 Fab Light chain 9606
835 4I1N 2 B Protein ca1697 (nanobody) 9844
836 5AWN 1 H Heavy chain of 3BC176 Fab 9606
837 5AWN 2 L Light chain of 3BC176 Fab 9606
838 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
839 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
840 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
841 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
842 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
843 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
844 5DR5 2 L AbD09097 Fab light chain 9606
845 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
846 2IH3 1 A FAB Heavy Chain 10090
847 2IH3 2 B FAB Light Chain 10090
848 4KQ3 1 L CNTO3186 light chain Fab 9606
849 4KQ3 2 H CNTO3186 heavy chain Fab 9606
850 6F0D 1 A, B VHH antibody BCD090-M2 9844
851 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
852 6AQ7 3 L POM6 FAB light CHAIN 10090
853 4JFX 1 A, L Fab light chain 9606
854 4JFX 2 B, H Fab heavy chain 9606
855 3SGE 1 I, L Light Chain 10090
856 3SGE 2 H, J Heavy Chain 10090
857 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
858 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
859 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
860 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
861 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
862 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
863 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
864 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
865 5FHB 1 H Antibody 100 Fab heavy chain 9606
866 5FHB 2 L Antibody 100 Fab light chain 9606
867 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
868 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
869 1JGU 1 L Antibody Light Chain 10090
870 1JGU 2 H Antibody Heavy Chain 10090
871 4I77 1 H Lebrikizumab heavy chain Fab 9606
872 4I77 2 L Lebrikizumab light chain Fab 9606
873 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
874 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
875 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
876 4O4Y 2 H 2095-2 heavy chain 9986
877 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
878 5OBF 1 H fAb Heavy chain 10090
879 5OBF 2 L fAb Light chain 10090
880 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
881 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
882 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
883 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
884 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
885 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
886 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
887 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
888 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
889 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
890 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
891 4GLR 3 I, K anti-ptau light chain light chain 9031
892 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
893 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
894 4HJG 1 A Trastuzumab light chain 9606
895 4HJG 2 B Trastuzumab heavy chain 9606
896 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
897 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
898 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
899 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
900 5I30 1 L Fab PL-2 light chain 10090
901 5I30 2 H Fab PL-2 heavy chain 10090
902 4W6X 2 B Nanobody NbFedF7 9844
903 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
904 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
905 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
906 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
907 3FN0 1 L Fab Z13e1 light chain 9606
908 3FN0 2 H Fab Z13e1 heavy chain 9606
909 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
910 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
911 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
912 4YHI 2 B, L aDabi-Fab2a light chain 9606
913 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
914 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
915 4OSU 1 H SM5-1 Fab Heavy Chain 9606
916 4OSU 2 L SM5-1 Fab Light Chain 9606
917 5JA9 2 A, B Nanobody 6 9844
918 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
919 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
920 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
921 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
922 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
923 1T2Q 1 L Fab NNA7 Heavy Chain 10090
924 1T2Q 2 H Fab NNA7 Light Chain 10090
925 6ELJ 1 A, H fAB heavy chain 9606
926 6ELJ 2 B, L fAB light chain 9606
927 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
928 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
929 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
930 4MAU 1 L C2244 light chain SEE REMARK 999 10090
931 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
932 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
933 3LEX 2 B, L 11f10 Antibody Light Chain 10090
934 6B0W 1 L 1710 antibody, light chain